These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8710788)

  • 1. [Tumor suppressor gene p53. Theoretical principles and their significance for pathology].
    Poremba C; Bankfalvi A; Dockhorn-Dworniczak B
    Pathologe; 1996 May; 17(3):181-8. PubMed ID: 8710788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [p53: an important or most overvalued tumor gene?].
    Schlegel U
    Laryngorhinootologie; 1994 Dec; 73(12):651-3. PubMed ID: 7840829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of the p53 gene.
    Sidransky D; Hollstein M
    Annu Rev Med; 1996; 47():285-301. PubMed ID: 8712782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
    Stiewe T; Haran TE
    Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The tumor suppressor gene p53 and its significance for dermatology].
    Lübbe J; Kleihues P; Burg G
    Hautarzt; 1994 Nov; 45(11):741-5. PubMed ID: 7822196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].
    Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
    Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor suppressor gene p53--function and significance in gastroenterology].
    Schoppmeyer K; Keim V; Mössner J
    Z Gastroenterol; 1997 Jun; 35(6):491-509. PubMed ID: 9281241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty years of p53 research: structural and functional aspects of the p53 protein.
    May P; May E
    Oncogene; 1999 Dec; 18(53):7621-36. PubMed ID: 10618702
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of tumor suppressor gene p53 in head and neck tumors].
    Preisler V; Kirchner S; Hagen R
    HNO; 1997 Sep; 45(9):659-62. PubMed ID: 9417443
    [No Abstract]   [Full Text] [Related]  

  • 11. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
    Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aflatoxin-B exposure does not lead to p53 mutations but results in enhanced liver cancer of Hupki (human p53 knock-in) mice.
    Tong WM; Lee MK; Galendo D; Wang ZQ; Sabapathy K
    Int J Cancer; 2006 Aug; 119(4):745-9. PubMed ID: 16557586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer.
    Benjamin CL; Melnikova VO; Ananthaswamy HN
    Adv Exp Med Biol; 2008; 624():265-82. PubMed ID: 18348463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Greenblatt MS; Bennett WP; Hollstein M; Harris CC
    Cancer Res; 1994 Sep; 54(18):4855-78. PubMed ID: 8069852
    [No Abstract]   [Full Text] [Related]  

  • 15. p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.
    Pappas K; Xu J; Zairis S; Resnick-Silverman L; Abate F; Steinbach N; Ozturk S; Saal LH; Su T; Cheung P; Schmidt H; Aaronson S; Hibshoosh H; Manfredi J; Rabadan R; Parsons R
    Mol Cancer Res; 2017 Aug; 15(8):1051-1062. PubMed ID: 28483946
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
    Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The p53 gene and protein in 2005: new results, promising opportunities].
    Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
    Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the TP53 gene in gastric and esophageal carcinogenesis.
    Bellini MF; Cadamuro AC; Succi M; Proença MA; Silva AE
    J Biomed Biotechnol; 2012; 2012():891961. PubMed ID: 22919278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
    Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [p53--a key gene for cancer development. Its central significance discloses itself to researchers step by step].
    Janssen K
    Fortschr Med; 1995 Dec; 113(34):48-50. PubMed ID: 8575709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.